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 Interventions aiming at postponing or preventing the development of Alzheimer’s dementia 
(AD) should be implemented before the first clinical symptoms. It is therefore critical to 
identify individuals with incipient AD. The most inexpensive and non-invasive way to achieve 
this goal is the use of cognitive tests that are sensitive to initial AD cerebral pathology. More 
specifically, the earliest cognitive deficit should be one that affects the specific function that 
is supported by the entorhinal and perirhinal cortices where neurofibrillary tangles start to 
accumulate [1]. Recent advances in cognitive neuroscience indicate that the entorhinal and 
perirhinal areas play a critical role in familiarity-based memory [2], the feeling that some 
information has been encountered before. This function contrasts with recollection, in which 
one recalls qualitative details about the encounter with the information. 
Although compelling and theoretically founded, the hypothesis that impaired familiarity may 
be a very early cognitive marker of AD has not been much investigated and led to 
inconsistent findings [for reviews, 3, 4]. Recently, Schoemaker, Poirier, Escobar, Gauthier, & 
Pruessner (2016, Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 
2, 132-139) addressed this hypothesis by testing cognitively healthy individuals who carry or 
not the Ɛ4 allele of the APOE gene. In this study, 21 carriers of APOEƐ4 (at risk for AD) and 60 
non-carriers performed a memory task in which they studied pictures of faces under two 
conditions that differed in terms of the spatial location of the face, the color of the 
background, and the judgement to make about each face.  Then, participants had to 
recognize the faces studied under the two conditions among new faces. For each face, they 
had to indicate whether the face had been presented, and if so, in which condition. In this 
task, recollection was indexed by the proportion of targets that were correctly identified as 
old and that were also attributed to the correct encoding condition. In contrast, familiarity 
was measured by the proportion of targets that were correctly recognized as old, but that 
the participant could not attribute to the correct encoding condition. The results showed 
that APOEƐ4 carriers and non-carriers did not differ on the recollection score, but APOEƐ4 
carriers had a significantly poorer familiarity score. Schoemaker et al. (2016) [5] concluded 
that individuals at increased risk of developing AD have impaired familiarity. With the caveat 
that one does not know how many participants will eventually develop AD, as carefully 
considered by the authors in their discussion, these findings may represent a first step 
towards supporting the idea of familiarity impairment as an early and specific marker of 
Alzheimer’s disease. However, we would like to suggest that the results do not support (nor 
contradict) such hypothesis. In this study, recollection and familiarity scores were derived 
from target faces only and were indexed by the ability to recall (or not) in which condition 
the face was presented (i.e., source attribution). Critically, familiarity was measured as the 
absence of recollection. Yet, a portion of recollected faces also probably entailed familiarity 
for the faces, as recollection and familiarity can co-occur. As a consequence, the contribution 
of familiarity may have been underestimated [6]. Moreover, even if a participant failed to 
recollect the encoding condition, s/he may have recalled other details associated with a 
target face (e.g., personal thoughts, emotional reaction). In other words, the familiarity 
score may encompass a portion of non-criterial recollection [7]. Finally, the poorer familiarity 
score in APOEƐ4 carriers may actually reflect fewer instances of failed recollection. Indeed, 
when considering the proportion of recognized targets (i.e., hits) that were accompanied by 
incorrect source attribution (from the means in Table 3 [5]), it appears that failure to 
retrieve the source occurred for about 53% of the hits in APOEƐ4 carriers versus around 61% 
in non-carriers. So, if this difference is significant, the poorer familiarity sore in APOEƐ4 
carriers may actually mean that, when correctly recognizing the faces, they retrieved the 
source more often. 
Additional studies aiming at testing the hypothesis that familiarity is selectively impaired in 
the initial stages of AD are warranted as this is a promising avenue for early detection of AD. 
The strongest piece of evidence in favor of this hypothesis would be the demonstration of a 
selective deficit of familiarity in a task that provides a pure measure of this memory function 
in participants who are shown to have incipient AD, i.e. cognitively healthy individuals who 
are positive on biomarkers of AD [8] and show cognitive decline in longitudinal assessments. 
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